Effects of molsidomine and lexipafant in hepatic ischaemia--reperfusion injury (Q44881846)

7 December 2017

Effects of molsidomine and lexipafant in hepatic ischaemia--reperfusion injury (English)

1 reference

7 December 2017

0 references

1 reference

Mustafa Aldemir

1

1 reference

7 December 2017

Mehmet Boşnak

2

1 reference

7 December 2017

Behçet Al

3

1 reference

7 December 2017

Hüseyin Büyükbayram

4

1 reference

7 December 2017

Ibrahim Taçyildiz

5

1 reference

7 December 2017

1 March 2004

1 reference

7 December 2017

1 reference

7 December 2017

35

1 reference

7 December 2017

3

1 reference

7 December 2017

232-237

1 reference

Cytokine toxicity and induction of NO synthase activity in cultured mouse hepatocytes

7 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Sinusoidal endothelial cell injury during hepatic preservation and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Nitric oxide and oxygen radicals: a question of balance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

To stick or not to stick: the new leukocyte homing paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Increased levels of platelet-activating factor in blood following intestinal ischemia in the dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Amelioration of experimental acute pancreatitis with a potent platelet-activating factor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Role of leukotriene B4 in the pathogenesis of hepatic ischemia-reperfusion injury in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Cyclic GMP as the mediator of molsidomine-induced vasodilatation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Mechanism of vasodilation by molsidomine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Platelet activating factor antagonism reduces the systemic inflammatory response in a murine model of acute pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Platelet-activating factor augments tumor necrosis factor and procoagulant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Lexipafant (BB-882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Pharmacologic modulation of experimental postischemic hepatic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Prospects for treatment of free radical-mediated tissue injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Tumor necrosis factor-induced, superoxide-mediated neutrophil accumulation in cold ischemic/reperfused rat liver.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Nitric oxide suppression reversibly attenuates mitochondrial dysfunction and cholestasis in endotoxemic rat liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Beneficial effects of lexipafant, a PAF antagonist on gut barrier dysfunction caused by intestinal ischemia and reperfusion in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

Molsidomine increases endotoxic survival and decreases cytokine production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2803%2900217-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0020-1383(03)00217-1

1 reference

7 December 2017

1 reference